| Dr Samantha Beth Rodgers, MD | |
|
3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 | |
| (210) 916-2020 | |
| Not Available |
| Full Name | Dr Samantha Beth Rodgers |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 3551 Roger Brooke Dr, Fort Sam Houston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891992665 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0101245588 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samantha Beth Rodgers, MD 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 Ph: (210) 916-2020 | Dr Samantha Beth Rodgers, MD 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 Ph: (210) 916-2020 |
News Archive
Mice growing up in a basic cage maintain lifelong visual cortex plasticity if their parents were raised in an environment that promoted social interaction and physical and mental stimulation, according to a multigenerational study published in eNeuro.
Stephen Hammond, MD, a fourth-year resident in clinical and anatomic pathology at Boston Medical Center (BMC), recently received the highly coveted Resident Leadership Representative Award from the American Society for Clinical Pathology (ASCP) for demonstrating leadership and promoting ASCP membership and resident activities.
AllAfrica.com reports on a "fellowship hosted by the U.N. Foundation" last week "to educate the media about progress that has been made on the Millennium Development Goals (MDGs) thus far and what still needs to be done before the 2015 target date for achieving them."
MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance today announces that the first group of healthy male volunteers have been dosed in a Phase I clinical trial assessing the safety and tolerability of an oral formulation of MGB-BP-3, for use in the treatment of Clostridium difficile infections.
Adults hospitalised with H1N1 influenza during the 2009–2010 pandemic were 25% less likely to die from the disease if they were given antiviral drugs called neuraminidase inhibitors (NAIs) such as Tamiflu, according to a large meta-analysis involving more than 29 000 patients from 38 countries, published in The Lancet Respiratory Medicine journal. The findings also indicate that treatment within 2 days of flu symptoms developing halved the risk of death compared with later treatment or no treatment.
› Verified 7 days ago
Benjamin Chacko, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Brooke Army Medical Center. Mche-qd/ Credentials, Fort Sam Houston, TX 78234 Phone: 210-916-1245 | |
Dr. Wesley Brundridge, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 | |
Sheri Lynn Demartelaere, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Brooke Army Medical Center, Mche-qd Credentials, Fort Sam Houston, TX 78234 Phone: 210-916-2460 | |
Dr. Donald Angelo Gagliano, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Bamc, Attn: Mche-qd (credentials), Fort Sam Houston, TX 78234 Phone: 210-221-8558 Fax: 210-221-8744 | |
Nikhil Jai Godbole, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 253-968-2020 | |
Dr. Sien Chen, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 | |
Dr. Darrel K. Carlton, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr Dept Of, Fort Sam Houston, TX 78234 Phone: 210-539-9582 |